Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

| More on:
Successful group of people applauding in a business meeting and looking very happy.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With so many shares to choose from on the Australian share market, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.

Three top ASX shares that leading brokers have named as buys this week are listed below. Here's why they are bullish on them:

Accent Group Ltd (ASX: AX1)

According to a note out of Citi, its analysts have upgraded this footwear retailer's shares to a buy rating with an improved price target of $2.57. This follows the release of the company's half year results last week. Citi was pleased with the results and particularly the improvements in its sales performance so far in the second half of FY 2025. It also highlights that the company's store network has been growing at a quicker than expected rate and believes that cost reductions will start to show in the second half and support a strong full year result in August. The Accent share price is trading at $2.06 on Monday afternoon.

Codan Ltd (ASX: CDA)

A note out of Goldman Sachs reveals that its analysts have retained their buy rating on this metal detector company's shares with an improved price target of $18.50. The broker notes that Codan delivered a half year result that ahead of consensus estimates thanks to strength in the Comms and Metal Detection segments. And while Codan is guiding to revenue growth of >15% for the full year, Goldman believes this is conservative and expects the company to outperform it. In fact, the broker estimates that Codan will achieve revenue growth of 23% for FY 2025. This is expected to lead to full year net profit after tax of $100 million. And with Goldman expecting increases to $123 million in FY 2026 and then $144 million in FY 2027, it feels that its shares are still good value at 29x forward earnings. The Codan share price is fetching $16.27 at the time of writing.

Telix Pharmaceuticals Ltd (ASX: TLX)

Analysts at Bell Potter have upgraded this radiopharmaceuticals company's shares to a buy rating with a vastly improved price target of $36.00. According to the note, the broker highlights that Telix delivered earnings 14% below consensus estimates during FY 2024. However, it is willing to overlook this due to its "glowing" outlook. This is being driven by a combination of acquisitions, organic growth, and product launches. The key Illuccix product will be important and is forecast to deliver revenue growth of 24% to $1 billion in FY 2025. All in all, Bell Potter points out that Telix remains laser focussed on accelerating its extensive clinical pipeline to market and will continue to spend aggressively through 2027 in order to achieve this goal. The Telix share price is trading at $30.19 this afternoon.

Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor James Mickleboro has positions in Accent Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group and Telix Pharmaceuticals. The Motley Fool Australia has recommended Accent Group and Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Suncorp share price Businessman cheering and smiling on smartphone
Broker Notes

5 ASX 200 shares for smart investors to buy in July

Brokers think these shares could be in the buy zone ahead of the new month.

Read more »

A group of businesspeople clapping.
Broker Notes

Bell Potter names the best ASX 200 shares to buy in FY26

The broker has good things to say about these shares.

Read more »

Man on his laptop standing next to data centres.
Broker Notes

Macquarie tips 54% upside for NextDC shares

NextDC shares certainly have momentum.

Read more »

Two lab workers fist pump each other.
Broker Notes

What's JP Morgan's price target on CSL shares?

Are CSL shares undervalued or will they continue to underperform?

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

Macquarie tips 33% return for this ASX 200 stock

The broker thinks this blue chip could be cheap at current levels.

Read more »

A woman in her late 30s holds her hands out either side with the palms up as if indicating she doesn't know the answer to a question. She has a quizzical look on her face.
Broker Notes

The A2 Milk share price: Buy, hold, sell?

Let's see what Bell Potter is saying about this popular stock.

Read more »

A smiling woman holds a Facebook like sign above her head.
Broker Notes

Morgans names 2 top ASX shares to buy now

What is the broker recommending to clients this week?

Read more »

It's raining cash for this man, as he throws money into the air with a big smile on his face.
Broker Notes

2 of the best ASX 200 shares that money can buy

Let's see why Bell Potter thinks these are among the best shares to buy now.

Read more »